{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:03:28Z","timestamp":1781809408142,"version":"3.54.5"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.phrs.2022.106547","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T22:21:13Z","timestamp":1667514073000},"page":"106547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Tantali fibromyalgic supplicium: Is there any relief with the antidepressant employment? A systematic review"],"prefix":"10.1016","volume":"186","author":[{"given":"Sara","family":"Ilari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Carmela","family":"Passacatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Malafoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Oppedisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Maiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Gliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Raffaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Muscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib1","first-page":"44","article-title":"Neuropathic pain and its relationship with clinical findings in patients with fibromyalgia","volume":"59","author":"Akaltun","year":"2022","journal-title":"Noro Psikiyatr Ars."},{"issue":"4","key":"10.1016\/j.phrs.2022.106547_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041499","article-title":"Identification of MOR-positive B cell as possible innovative biomarker (Mu lympho-marker) for chronic pain diagnosis in patients with fibromyalgia and osteoarthritis diseases","volume":"21","author":"Raffaeli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2022.106547_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/AJP.0000000000000354","article-title":"Fibromyalgia and chronic pain syndromes: a white paper detailing current challenges in the field","volume":"32","author":"Arnold","year":"2016","journal-title":"Clin. J. Pain"},{"issue":"8","key":"10.1016\/j.phrs.2022.106547_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2022.106547_bib5","article-title":"Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers","volume":"15","author":"D'Agnelli","year":"2019","journal-title":"Mol. Pain"},{"issue":"6","key":"10.1016\/j.phrs.2022.106547_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1590\/S0482-50042011000600006","article-title":"Influence of the interaction between environmental quality and T102C SNP in the HTR2A gene on fibromyalgia susceptibility","volume":"51","author":"Mergener","year":"2011","journal-title":"Rev. Bras. Reumatol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291720004547","article-title":"The role of lifetime stressors in adult fibromyalgia: systematic review and meta-analysis of case-control studies","volume":"51","author":"Kaleycheva","year":"2021","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.phrs.2022.106547_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/acr.22742","article-title":"Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia","volume":"68","author":"Wolfe","year":"2016","journal-title":"Arthritis Care Res."},{"issue":"10","key":"10.1016\/j.phrs.2022.106547_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17103634","article-title":"Low-intensity physical exercise improves pain catastrophizing and other psychological and physical aspects in women with fibromyalgia: a randomized controlled trial","volume":"17","author":"Izquierdo-Alventosa","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/bs12030071","article-title":"Physical activity and depression in adolescents: evidence from china family panel studies","volume":"12","author":"Gu","year":"2022","journal-title":"Behav. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2022.106547_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19084870","article-title":"Exploring the relationship between fibromyalgia-related fatigue, physical activity, and quality of life","volume":"19","author":"Alvarez","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.phrs.2022.106547_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/PRBM.S178240","article-title":"Psychological impact of fibromyalgia: current perspectives","volume":"12","author":"Galvez-Sanchez","year":"2019","journal-title":"Psychol. Res. Behav. Manag."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.rdc.2022.02.006","article-title":"Fibromyalgia: recognition and management in the primary care office","volume":"48","author":"Gota","year":"2022","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.phrs.2022.106547_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.coph.2021.02.007","article-title":"Opportunities and challenges for nonaddictive interventions in chronic pain","volume":"57","author":"Malafoglia","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13030-021-00219-w","article-title":"Cognitive-behavioral therapy for management of mental health and stress-related disorders: recent advances in techniques and technologies","volume":"15","author":"Nakao","year":"2021","journal-title":"Biopsychosoc. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106547_bib17","first-page":"149","article-title":"Stress, depression and fibromyalgia","volume":"106","author":"Van Houdenhove","year":"2006","journal-title":"Acta Neurol. Belg."},{"issue":"7","key":"10.1016\/j.phrs.2022.106547_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166150","article-title":"Cationic liposome-encapsulated carotenoids as a potential treatment for fibromyalgia in an animal model","volume":"1867","author":"Elkholy","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.phrs.2022.106547_bib19","article-title":"Fibromyalgia and depression: a literature review of their shared aspects","volume":"14","author":"Yepez","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.phrs.2022.106547_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fmed.2017.00198","article-title":"Fibromyalgia syndrome: a metabolic approach grounded in biochemistry for the remission of symptoms","volume":"4","author":"Lattanzio","year":"2017","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40122-021-00279-4","article-title":"Complex regional pain syndrome: a comprehensive review","volume":"10","author":"Taylor","year":"2021","journal-title":"Pain Ther."},{"key":"10.1016\/j.phrs.2022.106547_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fpsyg.2018.00442","article-title":"Alexithymia and depression affect quality of life in patients with chronic pain: a study on 205 patients with fibromyalgia","volume":"9","author":"Tesio","year":"2018","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106547_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.12968\/hmed.2012.73.4.211","article-title":"Fibromyalgia syndrome and depression: common pathways","volume":"73","author":"Dunne","year":"2012","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.phrs.2022.106547_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","article-title":"IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients","volume":"290","author":"Mendieta","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106547_bib25","article-title":"The influence of pro-inflammatory cytokines and genetic variants in the development of fibromyalgia: a traditional review","volume":"12","author":"Peck","year":"2020","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.phrs.2022.106547_bib26","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/rheumatology\/keab146","article-title":"Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis","volume":"60","author":"O'Mahony","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2022.106547_bib27","article-title":"The interplay between chronic pain, opioids, and the immune system","author":"Malafoglia","year":"2021","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12969-019-0320-y","article-title":"Patient-proxy agreement on health-related quality of life in juvenile fibromyalgia syndrome","volume":"17","author":"Gmuca","year":"2019","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"5","key":"10.1016\/j.phrs.2022.106547_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and US Food and Drug Administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.phrs.2022.106547_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2165\/00003495-200969090-00006","article-title":"Duloxetine: in patients with fibromyalgia","volume":"69","author":"Curran","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2022.106547_bib31","first-page":"CD008244","article-title":"Milnacipran for pain in fibromyalgia in adults","volume":"10","author":"Cording","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2022.106547_bib32","first-page":"CD011735","article-title":"Selective serotonin reuptake inhibitors for fibromyalgia syndrome","volume":"6","author":"Walitt","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2022.106547_bib33","first-page":"CD011824","article-title":"Amitriptyline for fibromyalgia in adults","volume":"5","author":"Moore","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2022.106547_bib34","doi-asserted-by":"crossref","first-page":"6541798","DOI":"10.1155\/2020\/6541798","article-title":"Current and emerging pharmacotherapy for fibromyalgia","volume":"2020","author":"Tzadok","year":"2020","journal-title":"Pain Res. Manag."},{"issue":"8","key":"10.1016\/j.phrs.2022.106547_bib35","first-page":"8","article-title":"1992--and beyond","volume":"1","author":"Quinn","year":"1991","journal-title":"Br. J. Theatre Nurs."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s42358-020-00137-5","article-title":"Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews","volume":"60","author":"de Farias","year":"2020","journal-title":"Adv. Rheuma"},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib38","doi-asserted-by":"crossref","first-page":"25532","DOI":"10.52965\/001c.25532","article-title":"Milnacipran for the treatment of fibromyalgia","volume":"9","author":"Gupta","year":"2021","journal-title":"Health Psychol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0301-0082(84)90018-2","article-title":"Lead neurotoxicity: a review of the biochemical, neurochemical and drug induced behavioural evidence","volume":"22","author":"Winder","year":"1984","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106547_bib40","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clinthera.2010.08.003","article-title":"Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"32","author":"Arnold","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2022.106547_bib41","unstructured":"Long-term Use of Cyclobenzaprine for Pain: A Review of the Clinical Effectiveness, Ottawa, ON, 2015."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.20076","article-title":"Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis","volume":"51","author":"Tofferi","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780370106","article-title":"Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial","volume":"37","author":"Carette","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.phrs.2022.106547_bib44","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00296-018-4068-3","article-title":"The role of mirtazapine in patients with fibromyalgia: a systematic review","volume":"38","author":"Ottman","year":"2018","journal-title":"Rheumatol. Int."},{"issue":"7\u20138","key":"10.1016\/j.phrs.2022.106547_bib45","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1345\/aph.1R725","article-title":"Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study","volume":"47","author":"Yeephu","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.phrs.2022.106547_bib46","doi-asserted-by":"crossref","unstructured":"M.S. McDonagh, S.S. Selph, D.I. Buckley, R.S. Holmes, K. Mauer, S. Ramirez, F.C. Hsu, T. Dana, R. Fu, R. Chou, Nonopioid Pharmacologic Treatments for Chronic Pain, Rockville (MD), 2020.","DOI":"10.23970\/AHRQEPCCER228"},{"key":"10.1016\/j.phrs.2022.106547_bib47","first-page":"CD009318","article-title":"Lacosamide for neuropathic pain and fibromyalgia in adults","volume":"2","author":"Hearn","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2022.106547_bib48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib49","first-page":"225","article-title":"Radical removal of membranous obstruction of inferior vena cava","volume":"106","author":"Xu","year":"1993","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-018-1242-0","article-title":"Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis","volume":"17","author":"Bolton","year":"2019","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.phrs.2022.106547_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40263-019-00623-5","article-title":"Revisiting tramadol: a multi-modal agent for pain management","volume":"33","author":"Barakat","year":"2019","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib52","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.phrs.2022.106547_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.31486\/toj.21.0038","article-title":"Systematic review of the use of intravenous ketamine for fibromyalgia","volume":"21","author":"Pastrak","year":"2021","journal-title":"Ochsner J."},{"issue":"12","key":"10.1016\/j.phrs.2022.106547_bib54","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","article-title":"Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up","volume":"155","author":"Olivan-Blazquez","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2022.106547_bib55","series-title":"Anti-NMDA Receptor Encephalitis","author":"D.S.F.L.","year":"2022"},{"issue":"6","key":"10.1016\/j.phrs.2022.106547_bib56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pmn.2020.07.003","article-title":"Use of complementary and alternative medicine in fibromyalgia: results of an online survey","volume":"21","author":"Pfalzgraf","year":"2020","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.phrs.2022.106547_bib57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2018.04.056","article-title":"Fibromyalgia and nutrition: therapeutic possibilities?","volume":"103","author":"Bjorklund","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4068\/cmj.2015.51.2.58","article-title":"Exploring genetic susceptibility to fibromyalgia","volume":"51","author":"Park","year":"2015","journal-title":"Chonnam Med. J."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.reuma.2020.04.012","article-title":"Nutritional supplementation with coenzyme Q10, tryptophan and magnesium in fibromyalgia treatment: a letter to Editor","volume":"18","author":"Gomez-Centeno","year":"2022","journal-title":"Reumatol. Clin."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211824","article-title":"Does aerobic exercise associated with tryptophan supplementation attenuates hyperalgesia and inflammation in female rats with experimental fibromyalgia?","volume":"14","author":"Rezende","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.phrs.2022.106547_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17072227","article-title":"Psychological and sleep effects of tryptophan and magnesium-enriched mediterranean diet in women with fibromyalgia","volume":"17","author":"Martinez-Rodriguez","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12969-019-0375-9","article-title":"C.R.I. for the, pain, functional disability, and their association in juvenile fibromyalgia compared to other pediatric rheumatic diseases","volume":"17","author":"Connelly","year":"2019","journal-title":"Pediatr. Rheumatol. Online J"},{"key":"10.1016\/j.phrs.2022.106547_bib63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/JPR.S351320","article-title":"Effect of acupuncture on pain, fatigue, sleep, physical function, stiffness, well-being, and safety in fibromyalgia: a systematic review and meta-analysis","volume":"15","author":"Zheng","year":"2022","journal-title":"J. Pain Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib64","article-title":"Massage therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib65","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/papr.12585","article-title":"Healthcare costs and medication adherence among patients with fibromyalgia: combination medication vs. duloxetine, milnacipran, venlafaxine, and pregabalin initiators","volume":"18","author":"Marlow","year":"2018","journal-title":"Pain Pract."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10067-021-05890-6","article-title":"No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial","volume":"41","author":"Ghavidel-Parsa","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40199-019-00257-4","article-title":"Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial","volume":"27","author":"Bidari","year":"2019","journal-title":"Daru"},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib68","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1038\/s41598-019-45976-5","article-title":"Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy","volume":"9","author":"Gejl","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pneurobio.2008.04.004","article-title":"BDNF as a pain modulator","volume":"85","author":"Merighi","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106547_bib70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpain.2007.05.002","article-title":"Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome","volume":"8","author":"Sarchielli","year":"2007","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.phrs.2022.106547_bib71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s11064-010-0129-z","article-title":"Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia","volume":"35","author":"Haas","year":"2010","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuint.2013.01.001","article-title":"Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety","volume":"62","author":"Nugraha","year":"2013","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.phrs.2022.106547_bib73","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jpsychires.2006.02.007","article-title":"Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants","volume":"41","author":"Laske","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12891-022-05369-8","article-title":"Comparison of the serum brain-derived neurotrophic factor (BDNF) between fibromyalgia and nociceptive pain groups; and effect of duloxetine on the BDNF level","volume":"23","author":"Bidari","year":"2022","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.phrs.2022.106547_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-019-0325-6","article-title":"Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial","volume":"17","author":"Upadhyaya","year":"2019","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib76","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/pm\/pnx091","article-title":"Effect of baseline characteristics on the pain response to pregabalin in fibromyalgia patients with comorbid depression","volume":"19","author":"Silverman","year":"2018","journal-title":"Pain Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106547_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1533-2500.2010.00431.x","article-title":"Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine","volume":"11","author":"Zhao","year":"2011","journal-title":"Pain Pract."},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib78","first-page":"263","article-title":"Treatment patterns associated with acr-recommended medications in the management of fibromyalgia in the United States","volume":"22","author":"Liu","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.phrs.2022.106547_bib79","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.phrs.2018.10.025","article-title":"The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: an integrative review of evidence, mechanisms, and clinical implications","volume":"139","author":"Fornaro","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2022.106547_bib80","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3899\/jrheum.170098","article-title":"Adherence and persistence with drug therapy among fibromyalgia patients: data from a large health maintenance organization","volume":"44","author":"Ben-Ami Shor","year":"2017","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106547_bib81","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1515\/jcim-2020-0116","article-title":"Okada purifying therapy in combination with duloxetine vs. duloxetine alone in patients with TMD and fibromyalgia: a randomized clinical study","volume":"18","author":"Bruti","year":"2020","journal-title":"J. Complement. Integr. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106547_bib82","first-page":"513","article-title":"Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: a randomized double-blind clinical trial","volume":"8","author":"Shakiba","year":"2018","journal-title":"Avicenna J. Phytomed."},{"issue":"6","key":"10.1016\/j.phrs.2022.106547_bib83","first-page":"287","article-title":"Clinical applications of saffron (Crocus sativus) and its constituents: a review","volume":"65","author":"Moshiri","year":"2015","journal-title":"Drug Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106547_bib84","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00404-018-4655-2","article-title":"Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial","volume":"297","author":"Kashani","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.phrs.2022.106547_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105963","article-title":"Saffron, as an adjunct therapy, contributes to relieve depression symptoms: an umbrella meta-analysis","volume":"175","author":"Musazadeh","year":"2022","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.phrs.2022.106547_bib86","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-0042-116159","article-title":"Crocus sativus L. versus citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trial","volume":"50","author":"Ghajar","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.phrs.2022.106547_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14196\/mjiri.32.29","article-title":"Effects of vitamin D optimization on quality of life of patients with fibromyalgia: a randomized controlled trial","volume":"32","author":"Mirzaei","year":"2018","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"10.1016\/j.phrs.2022.106547_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106421","article-title":"Anxiolytic and antidepressive potentials of rosmarinic acid: a review with a focus on antioxidant and anti-inflammatory effects","volume":"184","author":"Dahchour","year":"2022","journal-title":"Pharmacol. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822004935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822004935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:38:22Z","timestamp":1760913502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822004935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":88,"alternative-id":["S1043661822004935"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106547","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tantali fibromyalgic supplicium: Is there any relief with the antidepressant employment? A systematic review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106547"}}